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We have studied 52 new HHV8 strains by sequencing the complete hypervariable K1 gene and genotyping the K14.1/K15
loci located at both sides, respectively, of the viral genome. The samples originated from 49 patients with Kaposi’s sarcoma
(KS; 32 patients), multicentric Castleman’s disease (MCD; 12 patients), or primary effusion lymphoma (PEL; 5 patients).
Among these patients, 32 were of African origin (West and Central African countries and Creoles from French Guiana) and
the 17 others were mostly French homosexuals. Comprehensive phylogenetic studies allowed the identification of distinct
groups within the three already known main subtypes. Interestingly, two new sequences that did not cluster within a known
subtype or group could be considered as prototypes of early/ancient variants of the C subtype and A/C set, respectively.
Among the 32 African strains, the majority were either of the B subtype (13 cases) or of the A5 group (11 cases), indicating
that this latter genotype is frequent and widespread in Africa. In contrast, a subtype C strain infected most of the 17 other
patients. PCR-based genotyping of the K14.1/K15 loci revealed an overall predominance of P subtype, except in the A5 and
B K1 groups, in which the P and M alleles were equally represented. The implications of these data on the evolution and
spread of HHV8 among human African populations are discussed. © 2000 Academic Press
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Kaposi’s sarcoma-associated herpesvirus (KSHV),
also known as Human herpesvirus 8 (HHV8), is a new g2
herpesvirus that was first identified in a biopsy tumor
from an AIDS-related Kaposi’s sarcoma (KS) (Chang et
al., 1994). This virus is now considered as the etiologic
agent of all clinico-epidemiologic forms of KS (Boshoff et
al., 1995; Chuck et al., 1996; Dupin et al., 1995; Huang et
al., 1995; Moore and Chang, 1995; Whitby et al., 1995), a
tumor of mixed cellularity, occurring frequently during
HIV-1 infection, especially among homosexual men (ep-
idemic KS) and in transplant recipients. More rarely, such
tumor occurs among non-HIV-infected individuals, either
aged men of Mediterranean and Middle East origin (clas-
sic KS) or in inhabitants from East and Central Africa
(endemic KS) (Beral, 1991). Furthermore, HHV8 has also
been clearly associated with primary effusion lymphoma
(PEL), a rare and peculiar form of non-Hodgkin’s lym-
phoma of B-cell origin, occurring mainly, but not exclu-
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60sively, in HIV-1-infected individuals (Cesarman et al.,
1995; Nador et al., 1996) and in some aggressive cases
of multicentric Castleman’s disease (MCD), a B-cell poly-
clonal lymphoproliferation with specific pathologic fea-
tures (Gessain et al., 1996; Soulier et al., 1995).
Recent epidemiologic surveys indicate that HHV8 is
not a widespread ubiquitous virus but that its presence
is mainly restricted to areas of high endemicity for clas-
sic or endemic forms of KS. Thus HHV8 infection, as
determined by the presence of specific antibodies di-
rected against HHV8 latent and/or lytic antigens, is rare
(,5%) in the adult populations of North America and of
the Northern and Western part of Europe, while it is more
prevalent (5–20%) in comparable populations of some
Mediterranean countries such as Italy, Greece, Egypt,
and Israel (Schulz, 1998). On the other hand, HHV8 is
very frequent in East and Central Africa, where its sero-
prevalence can reach 70% among adults (de The´ et al.,
1999). The modes of transmission of HHV8 in endemic
areas remain obscure. Indeed, among homosexual men
of the occidental world, HHV8 transmission during sex
has been established (Martin et al., 1998). However, the
occurrence of KS in children and the high seropreva-
61MOLECULAR EPIDEMIOLOGY OF HHV8 IN AFRICAlence of HHV8 infection in children in Central and East
Africa indicate the existence of nonsexual routes of
HHV8 transmission (Gessain et al., 1999). Recent epide-
miologic data strongly suggest that, in endemic popula-
tions, the main routes of HHV8 transmission are from
mother to child and between siblings (Plancoulaine et al.,
2000).
Initial studies conducted on the genetic variability and
polymorphism of HHV8 focused on three small gene
fragments of the ORF 26 (minor capsid gene) and ORF 75
(tegument region) from KS specimens. They demon-
strated the existence of three distinct molecular patterns,
however, with a very low overall nucleotide variability
(,3%) among these three genotypes (Fouchard et al.,
2000; Kasolo et al., 1998; Zong et al., 1997). Molecular
epidemiologic studies exploiting the significantly higher
genetic variability of the K1 gene were recently published
(Cook et al., 1999; Kasolo et al., 1998; Lacoste et al.,
2000b; Meng et al., 1999; Nicholas et al., 1998; Zong et
al., 1999). The open reading frame (ORF) K1, located at
the left end of the genome, encodes for a transmem-
brane, highly glycosylated protein, that exhibits some
similarities with the immunoglobulin receptor family (La-
gunoff and Ganem, 1997; Lee et al., 1998). Four major K1
subtypes (called either A, B, C, and D or I, II, III, and IV),
which appear, at least for some of them, linked to the
geographic origin of the samples, were previously iden-
tified (Cook et al., 1999; Hayward, 1999; Kasolo et al.,
1998; Meng et al., 1999; Zong et al., 1999). Thus, HHV8 B
strains seem to predominate in Africa and are phyloge-
netically more distant from groups A and C, which are
found in Europe and the United States, than A and C from
each other (Cook et al., 1999; Zong et al., 1999). Further-
more, the few subtype D strains are restricted to Pacific
island heritage (Meng et al., 1999; Zong et al., 1999).
So far, the great majority of the published K1 se-
quences were obtained from patients originating from
the United States and to a lesser extent from European
countries (Italy, Greece, and Denmark). Regarding Africa,
considered as the most important reservoir of HHV8
infection, around 40 K1 sequences (including only 13
complete ones) were previously reported, most of them
originating from East Africa (Uganda, Tanzania, and Zam-
bia) (Cook et al., 1999; Hayward, 1999; Kasolo et al., 1998;
Meng et al., 1999; Zong et al., 1999), an area of very high
endemicity for HHV8 and KS. Only nine strains (three
complete K1 sequences and six partial ones) were re-
ported for West Africa (Gambia), a region of lower ende-
micity for HHV8 and KS (Cook et al., 1999).
The extreme right-hand side (RHS) genomic region
comprises K14.1 and K15 genes. The latter code for an
integral membrane protein related to the LMP2 latency
protein of Epstein–Barr virus (Choi et al., 2000). Recent
data indicate the existence of two highly divergent sub-types in this genomic region, labeled P (for predominant)
and M (for minor) subtypes (Poole et al., 1999).
Regarding the patients’ diseases, most (.75%) of the
reported HHV8 K1 sequences originated so far from
Kaposi’s sarcoma, with only few cases originating from
MCD or primary PEL tumors.
Thus, the two goals of this molecular epidemiologic
study were to gain new insights on the genetic variability
and evolution of HHV8 by studying the complete K1 gene
sequence and by genotyping the K14.1/K15 loci of viral
isolates from: (1) patients originating from North (Algeria,
Mauritania), West (Senegal, Togo), and Central Africa
(Central African Republic, Cameroon, Congo), regions
with different levels of HHV8 seroprevalence and KS
incidence, but also from patients of original West African
ancestry but living in South America for a few centuries
(Creoles from French Guiana); and (2) patients with
HHV8-associated diseases other that KS, i.e., PEL and
MCD.
RESULTS
Patients: K1 strains, diseases, and geographic origin
A total of 52 new sequences of the complete K1 gene,
originating from 49 patients were generated. The main
clinical and epidemiologic features (age, sex, risk group,
diagnosis, geographic origin) of these 49 patients and 52
samples are listed in Table 1. There were 32 KS tumor
samples, either from cutaneous lesions or lymph nodes
from patients presenting the different forms of KS (23
epidemic, two classic, five endemic, two posttransplant).
We also studied 12 MCD samples, either from lymph
nodes, spleens, or PBMCs of 12 patients with mainly
HIV-associated MCD (only two patients, one from Spain
and one from Mauritania, were non-HIV infected), and
five tumor PEL samples (ascitic, pleural effusions or
diaphragm, pericardic biopsies) originating from HIV-
associated PEL patients. Furthermore, we also se-
quenced the K1 gene of three cell lines established from
PEL tumor effusions, including a new one (CRA-BCBL)
recently established in our laboratory (Lacoste et al.,
2000a).
Regarding the geographic origin and ethnic back-
ground of the 49 studied patients, there were 32 patients
of African origin, of whom 21 originated from North, West,
and Central African countries, and also 11 Creoles of
African heritage ancestry, currently living in South Amer-
ica (French Guiana). The other 17 patients were mainly
Caucasian patients from France.
K1 genetic variability
Control. Each PCR run contained several negative
controls and, in all cases, HHV8 DNA was not detected
in these PCR controls. Furthermore, the following differ-
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Patients’ Samples Analyzed in This Study: Specimen Identification, Demographic Details, Geographic Origin,
and Clinical Characteristics of the 52 Samples
Specimen ID Age Sex HIV/Risk factors Country Diagnosis Material Accession number
K1-7/Ngo 27 M 1 CAR epidemic KS Cutaneous biopsy AF178779
K1-8/Dem 32 F 1 CAR epidemic KS Cutaneous biopsy AF178780
K1-20/Gon 34 M 1 CAR epidemic KS Cutaneous biopsy AF178789
K1-21/Gbo 27 F 1 CAR epidemic KS Cutaneous biopsy AF178790
K1-22/Yan 45 F 1 CAR epidemic KS Cutaneous biopsy AF178791
K1-23/Kok 28 M 1 CAR epidemic KS Cutaneous biopsy AF178792
K1-27/Ban 20 F 1 CAR epidemic KS Cutaneous biopsy AF178796
K1-31/Ren 33 F 1 CAR epidemic KS Cutaneous biopsy AF178798
K1-54/Kos 20 M 1 CAR epidemic KS Cutaneous biopsy AF171059
K1-58/Sar 38 F 1 CAR epidemic KS Cutaneous biopsy AF178823
K1-59/Sir 30 M 1 CAR epidemic KS Cutaneous biopsy AF178824
K1-34/E40 33 M 1 CAR MCD Lymph node AF178801
K1-14/Eko 20 F 1 Cameroon epidemic KS Cutaneous biopsy AF178784
K1-28/Djk 25 F 1 Cameroon epidemic KS Cutaneous biopsy AF178797
K1-46/Na 33 F 1 Cameroon epidemic KS Cutaneous biopsy AF171058
K1-12/Mou 53 M 1 Congo MCD Tonsil AF178783
K1-37/E44 32 M 1 Togo MCD Spleen AF178804
K1-52/Ali 27 M 1 Senegal epidemic KS Cutaneous biopsy AF178818
K1-55/Dia 57 M 2/post transplant Senegal transplant KS Cutaneous biopsy AF178820
K1-45/Min 59 F 2 Mauritania MCD Lymph node AF178812
K1-38/E65 35 M 1/IVDU Algeria MCD Spleen AF178805
K1-9/Tim 33 M 1 French Guiana epidemic KS Cutaneous biopsy AF171056
K1-11/Tho 53 M 1 French Guiana epidemic KS Cutaneous biopsy AF178782
K1-15/Seb 37 F 1 French Guiana epidemic KS Cutaneous biopsy AF178785
K1-19/Edm 53 F 1 French Guiana epidemic KS Cutaneous biopsy AF178788
K1-4/Voi 78 M 2 French Guiana endemic KS Cutaneous biopsy AF178776
K1-13/Lov 75 M 2/HTLV11 French Guiana endemic KS Cutaneous biopsy AF171057
K1-53/Zao 52 M 2/HTLV11 French Guiana endemic KS Cutaneous biopsy 9/94 AF178819
K1-60/Ced 78 M 2 French Guiana endemic KS Cutaneous biopsy AF178825
K1-6/Lad 62 M 2/post transplant French Guiana transplant KS Cutaneous biopsy AF178778
K1-57/Eti 61 M 2 French Guiana classic KS Cutaneous biopsy AF178822
K1-56/Dam 70 M 2 French Guiana endemic KS Cutaneous biopsy AF178821
K1-10/Bid 49 M 1/Homo France epidemic KS Pulmonary AF178781
K1-18/Hec 35 M 1/Homo France epidemic KS Oropharyngeal site AF178787
K1-33/Gar 61 M 2 France/Corsica classic KS Cutaneous biopsy AF178800
K1-1/663 51 M 1/Homo France MCD Lymph node AF178773
K1-2/691 37 M 1/Homo France MCD Spleen AF178774
K1-36/E68 47 F 1/transfusion? France/Corsica MCD Lymph node AF178803
K1-39/E37 47 M 1/Homo France MCD Spleen AF178806
K1-41/Fan 33 M 1/Homo France MCD Lymph node 1994 AF178808
K1-3/718 36 M 1/Homo/IVDU France PEL Ascitic fluid AF178775
K1-5/Pin 42 M 1/Homo France PEL Pericardic Biopsy AF178777
K1-26/Ph5 38 M 1/Homo France PEL Pleural effusion AF178795
K1-43/Ber 31 M 1/Homo France PEL Ascitic fluid AF178810
K1-63/Bri 44 M 1/Homo France PEL Pleural effusion AF178828
K1-25/Cas 68 M 2 Spain MCD Lymph node AF178794
K1-64/Bud 48 M 1 Turkey epidemic KS Lymph node AF178829
K1-44/Urr 36 M 1/Homo South America MCD Lymph node AF178811
K1-17/Fuj 42 M 1/Homo Japan epidemic KS Lymph node AF178786
K1-24/Cra France PEL/cell line Cell line AF178793
K1-32/Bcb USA PEL/cell line Cell line AF178799
K1-40/Bc1 USA PEL/cell line Cell line AF178807Note. KS, Kaposi’s sarcoma; MCD, multicentric Castleman disease; PEL, primary effusion lymphoma; Homo, homosexual; IVDU, intravenous drug
ser; 1, HIV-1 positive; 2, HIV-1 negative; HTLV11, human T-cell leukemia virus type 1 positive; CAR, Central African Republic.
63MOLECULAR EPIDEMIOLOGY OF HHV8 IN AFRICAent controls strongly suggested that the observed ge-
netic variability was real and not the result of nucleotide
misincorporation during PCR: (1) the nucleotide se-
quence of the complete K1 gene obtained from BCBL-1,
a cell line propagated for several months in our labora-
tory, was identical to its published sequence; (2) two
other samples were also amplified independently twice
and the resulting sequences, after TA cloning and se-
quencing, were identical; and (3) furthermore, as re-
ported in another previously published study (Lacoste et
al., 2000b), we performed some experiments, in our PCR
conditions, which showed a very low amplification re-
lated error. Thus, we are very confident that our results
can be interpreted without any ambiguity.
Overall variability. All of the 52 new obtained se-
quences (49 biopsies 1 3 cell lines) were different from
each other. These sequences exhibit among themselves
from 0.1% (K1-10/Bid vs. K1-41/Fan) to 17.5% (K1-37/E44
vs. K1-63/Bid) nucleotide divergence and from 0% (K1-
10/Bid vs. K1-41/Fan) to 35% (K1-56/Dam vs. K1-63/Bri)
amino acid divergence among pairwise compilations.
Phylogenetic studies. Since tree-building algorithms
rely on different assumptions, we used two different
methods, neighbor-joining (NJ) and DNA maximum par-
simony (DNAPARS), to increase the reliability of the de-
rived tree topologies. A first comprehensive phylogenetic
study was performed using our 52 new nucleotide se-
quences and all of the 41 other complete K1 nucleotide
sequences available in GenBank. As seen in Figs. 1A
and 1B, the four already known main subtypes (A, B, C,
D) were clearly identified on the basis of consistent
topological associations and high bootstrap values, in
the NJ and DNAPARS phylogenetic analyses. These two
methods of phylogenetic analysis reproducibly placed a
given sequence in a given subtype. Furthermore, 50 of
the new sequences were clearly located in a specific
known subtype, either A for 19 of them, B for 14, or C for
17. Moreover, none of the new 52 strains belonged to the
D subtype. Interestingly, as seen in two cases—K1-8/
Dem, a strain originating from an African patient with
HIV-associated KS living in Central African Republic, and
K1-43/Ber, a strain from a French Caucasian homosexual
male with an HIV-associated PEL—the obtained se-
quences did not cluster within a known subtype or group
in all phylogenetic analyses (NJ and DNAPARS) when
performed with the complete K1 sequence (Figs. 1A–1C).
Based on high bootstrap values, some groups of
strains can be individualized within the A, B, and C
molecular subtypes (Fig. 1). Indeed, within subtype A
three main groups exist. The first one comprises most of
the already published complete K1 sequences and six of
the new ones. It corresponds to the strains of the A1, A2,
and A4 subgroups of Zong et al. (1999) and to the A9
group of Cook et al. (1999). The second one corresponds
to the A3 subgroup of Zong et al. (1999). The third onecomprises, exclusively, 11 of the new sequences and
corresponds to the A5 subgroup of Zong et al. (1999), for
which only one complete amino acid sequence (OKS3)
was previously available (Fig. 1C). Regarding subtype C,
five main groups were supported by high bootstrap val-
ues in all analyses (Figs. 1A and 1B). The first one
comprises six new and two previously published se-
quences, including the BC2 strain, and corresponds to
the C3 prototype of Zong et al. (1999). The second con-
tains four new and three previously published se-
quences, including the K1 C Russian strain 78/48 (La-
coste et al., 2000b). The third group contains only one of
our new sequences, the main divergent one in the C
subtype (K1-63/Bri) and six published ones, including
BC3 and the German sequence (FrN-K1) obtained from
an epidemic KS biopsy (Neipel et al., 1997). These first
three groups correspond to the C9 group of Cook et al.
(1999), as defined for the nearly entire extracellular do-
main (amino acids [aa] 28–238). Finally, the two other
groups contain, respectively, six new sequences and two
published ones, including BBG1 (Morand et al., 1999),
and none of our sequences, but three published ones,
including the prototypic C1 strain (ASM72) of Zong et al.
(1999). These two latter groups are comprised in the C0
group of Cook et al. (1999). Regarding the B subtype,
three groups are identified. The first group contains 11
strains (including nine new ones and the B prototype
431KAP) and the second one comprises eight strains, of
which four are new. Finally, the third group contains only
a new highly divergent B strain, K1-60/Ced (Figs. 1A–1C),
which is well supported phylogenetically in all analyses
comprising the complete K1 region.
To examine the possibility that the two novel divergent
strains (K1-8/Dem and K1-43/Ber) could be recombinants
between subtypes or subgroups with an “intermediate”
phylogenetic position, as suggested by two previous
studies for some A/C strains (Cook et al., 1999; Zong et
al., 1999), we performed separate analyses using differ-
ent regions of the K1 gene as described by Cook et al.
(1999). NJ analyses of 93 sequences, including our 52
new ones, performed on the nearly entire extracellular
domain (aa 28–238), generated virtually identical trees to
those obtained with the complete K1 region or with the
shorter aa 28–142 region (including the VR1). In these
three analyses, neither of our two new strains was
closely positionally related to any of the previously rec-
ognized recombinants or “intermediate” strains (A/C, C9/
C0), BBG-1, UKma8, SKS1, SKS9, IER3, IER8, Ic9, IAp3,
GK17, and UgR1 (Cook et al., 1999; Zong et al., 1999).
K1-8/Dem can be thus considered as an early/ancient
variant of the C branch, while K1-43/Ber, located on the
outgroup B branch, can thus be designated as an early/
ancient variant of the whole set of A/C strains. When the
NJ analysis was done on a fragment comprising only the
membrane proximal domain (aa 148–238: VR2), the root
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66 LACOSTE ET AL.FIG. 1. Phylogenetic trees. (A) Phylogenetic tree constructed by the NJ method using the NEIGHBOR program of the PHYLIP package version
3.5c (University of Washington, Seattle) (Felsenstein, 1993) with an 870-bp fragment corresponding to the entire ORF K1 for 93 HHV8 isolates,
including (in bold) the 52 sequences generated in this work (in shaded bold, our samples from African patients) as well as the seven prototype
samples deposited by Zong et al. (1999), the seven Russian samples recently reported (Lacoste et al., 2000b), the 22 complete K1 sequences
reported by Cook et al. (1999), the K1 sequence of the BBG-1 cell line (Morand et al., 1999) (GenBank accession number AF042370), and one
KS strain (Neipel et al., 1997) (GenBank accession number U93872), here named FrN-K1. TKS10 was used as an outgroup to root the tree.
Bootstrap values were calculated for 500 trees and the numbers at some nodes (bootstrap values) indicate frequencies of occurrence for 100
trees. A–D correspond to the four subtypes; A1–A4, C1 and C3, and D1 and D2 correspond to groups within the subtypes described by Zong
et al. (1999). A9, C9, and C0 groupings reflect the Cook et al. (1999) classification scheme based on the (nearly) entire extracellular K1 domain
(aa 28–238). B1, B2, and B3 are the new proposed subgroups within B subtype. (B) Phylogenetic tree constructed by the DNAPARS method of
the PHYLIP package on the same 93 entire ORF K1 sequences. (C) Radial unrooted phylogenetic dendrogram generated by the NJ method on
the entire K1 protein for 98 HHV8 isolates, including (in bold) the 52 sequences generated in this work (in shaded bold, our samples from African
patients) as well as the seven prototype samples deposited by Zong et al. (1999); plus BCP1 (A19 prototype), OKS3 (A5), TKS11 (C2), SKS1 (C4),
and SKS9 (C5) sequences; the seven recently reported Russian samples (Lacoste et al., 2000b); the 22 complete K1 sequences reported by
Cook et al. (1999); the K1 sequence of the BBG-1 cell line (Morand et al., 1999) (GenBank accession number AF042370); and one KS strain
(Neipel et al., 1997) (GenBank accession number U93872), here named FrN-K1. TKS10 was used as an outgroup to root the tree. The numbers
at some nodes (bootstrap values) indicate frequencies of occurrence for 100 trees. A–D correspond to the four subtypes; A1–A5, C1–C5, and
D1, D2 correspond to groups within the subtypes described (Zong et al., 1999). C9 and C0 groupings reflect the Cook et al. (1999) classification
scheme based on the (nearly) entire extracellular K1 domain (aa 28–238). B1, B2, and B3 are the new proposed subgroups within B subtype.
Because of space constraints not all samples were labeled.
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67MOLECULAR EPIDEMIOLOGY OF HHV8 IN AFRICAof the tree shifted to a position within the large group of
A5 strains. Furthermore, while the positioning of K1-8/
Dem remained similar as an early C strain, in contrast
K1-43/Ber switched to a position near K1-8/Dem, sug-
gesting that the VR2 of K1-43/Ber may be related to the C
group isolate. Nevertheless, it is interesting to note that
neither of these two new strains possesses the 5-aa
deletion of the C subtype. Moreover, visual inspection of
the aa-specific mutations indicates that both strains pos-
sess, in the membrane proximal domain containing VR2
(aa 148–238), one A-like position at aa 169, one C-like
position (aa 156), and two A5/C0-like positions (aa 223
and aa 228). These data suggest these two last A5/C0-
specific positions, also observed in the BBG1, IAP3,
GK17, ASM72, TKS11, SKS1, and SKS9 strains, conferred
to all these strains the possibility of shifting from one
phylogenetic position to another, when comparing the
different regions of K1 sequence. In addition to specific
and unique mutations all over these sequences, visual
inspection of the sequence alignment of the membrane
distal domain further shows that K1-43/Ber and K1-8/
Dem possess in this region a combination of A- and
C-like positions. All these data argue against an A/C
recombination event in our two novel strains, rather ar-
guing in favor of independent evolution/selection of
these isolates.
In addition, comparison with all of the 168 complete or
partial K1 sequences, available either in GenBank or in
tables of the previously noted studies (Cook et al., 1999;
Fouchard et al., 2000; Kasolo et al., 1998; Lacoste et al.,
2000b; Meng et al., 1999; Zong et al., 1999), indicate that
neither of the two new divergent strains reported in our
present study (K1-8/Dem and K1-43/Ber) corresponds to
a previously reported sequence.
Genetic variability of K1 between subtypes and within
subtypes: pairwise comparison. The diversity values
within and between the four subtypes have been calcu-
lated. This comparative analysis was performed on 93
complete nucleotide sequences (52 new ones and 41
available in GenBank). As expected, the inter-subtype
nucleotide variability was higher than the intra-subtype
variability in the great majority of cases, ranging from
13% to 19.6% and from 0% to 7.4%, respectively, with the
exception of the two strains from subtype D, which di-
verged by 13.4%.
Regions of variations and functional relevance. The K1
genes of strains A and C were well conserved in the
N-terminal region (aa 1–19, the predicted signal peptide
sequence) and in the C-terminal region (aa 227–289, the
predicted hydrophobic transmembrane domain and the
small cytoplasmic domain). In contrast, the central region
(aa 20–226, a predicted extracellular domain), as previ-
ously shown, was more variable with two hypervariable
domains, aa 51–92 (VR1) and aa 191–228 (VR2). The K1 of
B strains also possessed VR1 and VR2 regions but
8
wshowed a much higher level of variability across the
entire gene, except for the transmembrane region (aa
228–253), which was largely invariant among the three
subtypes. Among the 18 cysteine residues and the nine
N-linked glycosylation sites, 12 cysteine residues (of
which 11 were in the predicted extracellular domain) and
five N-linked glycosylation sites were highly conserved.
Subtype-specific mutations were observed: at aa 4, sub-
type B strains gain a cysteine residue (Y4C) and lose one
at aa 279 (C279H), except for K1-27/Ban (Y4Y and
C279R). Other cysteine residues showed sporadic muta-
tions in individual patients: K1-57/Eti (C7Y), K1-37/E44
(C12F), K1-11/Tho (C12W), K1-56/Dam, and K1-59/Sir
(C244F). Some of the nine predicted N-linked glycosyla-
tion sites (NXS/NXT) presented subtype-specific muta-
tions. One motif at aa 43–45 was lost in subgroup A5,
while subtype C lost N-linked glycosylation sites at aa
150–152 (NQT 3 DQT) and subtype B lost one at aa
262–264 (NKT 3 SKT) as well as K1-7/Ngo, K1-8/Dem,
and K1-63/Bri (NKT3 KKT). Although the short cytoplas-
mic tail is highly variable, especially between subtype B
and the other subtypes with nearly 28% amino acids
differences, the ITAM motif (Lee et al., 1998), implicated
in intracellular pathways leading to proliferation, appears
to be highly conserved between all sequences (ITAM
motif of K1: DX10DYYSLX7YX2P). A specific deletion of 5
aa (positions 201–205) was found in all the C subtype
strains and a deletion of 1 aa (position 267) occurred in
the sequence K1-58/Sar. In addition, an insertion of 1 aa
at nucleotide position 65 (already observed in two Rus-
sian strains, 74/8T and 79/55 [Lacoste et al., 2000b]), in
he sequences K1-15/Seb and K1-28/Djk, occurred at this
osition, 65T and 65S, respectively.
enetic variability of the K14.1 and K15 genes
Molecular subtype characterization of the right-hand
ide (RHS) of the HHV8 genome, which comprises the
14.1 and K15 genes, was determined for 49 of the 52
amples, including the two control cell lines BC-1 and
CBL-1 of the M and P subtypes, respectively (Poole et
l., 1999). These 49 samples correspond to 47 different
atients. While specific amplification of ORF K15 subtype
gave a positive result (a 370-bp product) for 13 pa-
ients and a negative result (no PCR product) for 33
atients, a second strategy (see Materials and Methods)
ave a 450-bp product specific for subtype M for 13
atients and a 362-bp product specific for subtype P for
3 patients. Thus a perfect correlation was obtained
etween these two strategies (Table 2).
Regarding the correlation between K1 subtypes and
he P or M subtype of the K14.1/K15 loci, it was clear that
he great majority of the C K1 strains tested (13/15 5
7%) were of the P subtype. Furthermore, the P subtype
as also predominant (12/18 5 67%) among the A
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determined by two independent PCR assays as described under
Materials and Methods. CAR, Central African Republic.
68 LACOSTE ET AL.strains. However, among the 10 tested A5 strains, M (five
cases) and P (five cases) were equally represented,
while among the other A strains, seven of eight were of
the P subtype. Regarding the K1 B subtype (14 cases),
both M (five cases) and P (nine cases) genotypes were
represented (Table 2). Among the two divergent K1
strains, K1-43/Ber was the sole French patient belonging
to the M subtype. Moreover, there was no amplification
product with the last divergent K1 strain, K1-8/Dem with
both strategies, suggesting either a new divergent RHS
subtype or a large deletion of this region. An overall
summary of the available data and subgroup assign-
ments determined at the RHS loci of 47 KS, MCD, and
PEL patient samples and compared with the LHS ORF K1
data are listed in Table 2.
Variability of K1 and K14.1/K15 according to
geography and diseases
Regarding the geographic distribution of the different
K1 subtypes (Table 2), strains of the C subtype were
mainly restricted to the French Caucasian patients (11/
13 5 84.6%). The only exception among the French pa-
ients was a patient with a PEL infected by an A strain.
egarding the 32 African HHV8 strains, there were 14
trains of the B subtype, 13 of subtype A, of which 11
ere of A5 group, four of subtype C, and one with a new
ubtype, K1-8/Dem. Thus HHV8 B and A5 strains repre-
ent 78% (25/32) of the African strains. The three patients
rom Spain, Turkey, and Japan had a K1 A strain, and the
atient from South America was infected by a C strain.
egarding the geographic distribution of the M and P
ubtypes, 12 of the 13 (92.3%) French patients were
nfected by an HHV8 of the K14.1/K15 P subtype, while M
nd P subtypes were equally represented in the patients
f African origin (Table 2). Genotype-associated disease
as not observed for both K1 and K14.1/K15 genomic
egions, even for MCD.
DISCUSSION
In this report, we have analyzed the genetic variations
nd polymorphism of two different genomic regions of
HV8 (K1 and K14.1/K15), located respectively at the
eft-hand and right-hand sides of the viral genome. By
tudying 52 new viral strains obtained from the whole
pectrum of HHV8-associated tumors, we described
riginal features regarding the geographic distribution of
hese genotypes, especially in African patients. We also
dentified two new divergent viral strains and confirm the
pparent lack of specific disease association with such
enes.
ubtypes, groups, and new variants at the K1 locusTABLE 2
Correlation and Linkage between Left-Hand Side (LHS) and
Right-Hand Side (RHS) Loci of the HHV8 Genome
Specimen ID Country K1 subtype K14.1/K15 subtype
K1-7/Ngo CAR A5 M
K1-8/Dem CAR * ?
K1-20/Gon CAR C M
K1-21/Gbo CAR A5 M
K1-22/Yan CAR B1 M
K1-23/Kok CAR B2 P
K1-27/Ban CAR B1 P
K1-31/Ren CAR A5 P
K1-54/Kos CAR A5 M
K1-58/Sar CAR A5 P
K1-59/Sir CAR B1 P
K1-34/E40 CAR B1 M
K1-14/Eko Cameroon A5 M
K1-28/Djk Cameroon A5 P
K1-46/Na Cameroon A5 P
K1-12/Mou Congo B1 M
K1-37/E44 Togo B2 M
K1-52/Ali Senegal B2 P
K1-55/Dia Senegal C M
K1-45/Min Mauritania A P
K1-38/E65 Algeria C P
K1-9/Tim French Guiana B2 P
K1-11/Tho French Guiana B1 P
K1-15/Seb French Guiana A P
K1-19/Edm French Guiana B1 P
K1-4/Voi French Guiana C P
K1-13/Lov French Guiana A5 P
K1-60/Ced French Guiana B3 P
K1-6/Lad French Guiana A5 M
K1-57/Eti French Guiana B1 M
K1-56/Dam French Guiana B1 P
K1-10/Bid France C P
K1-18/Hec France C P
K1-33/Gar France/Corsica C P
K1-1/663 France C P
K1-2/691 France C P
K1-36/E68 France/Corsica C P
K1-39/E37 France C P
K1-41/Fan France C P
K1-3/718 France A P
K1-5/Pin France C P
K1-26/Ph5 France C P
K1-43/Ber France * M
K1-63/Bri France C P
K1-25/Cas Spain A P
K1-64/Bud Turkey A P
K1-17/Fuj Japan A P
K1-32/Bcb USA A3 P
K1-40/Bc1 USA A2 M
Note. Overall subgroup assignment determined at the LHS ORF K1
nd RHS ORF K14.1/K15 loci across the genome of KS, MCD, and
EL samples of the 49 studied patients. Specimen identifications
re classified as in Table 1 by geographic origin. Groups within
ubtypes A and C are not indicated, except for the A5 subgroup.
indicates the two divergent K1 sequences. ? indicates that there
as no amplification product. The K14.1/K15 M or P subtype wasBy performing a comprehensive phylogenetic study on
ll the available complete K1 sequences, including the
69MOLECULAR EPIDEMIOLOGY OF HHV8 IN AFRICA52 new ones generated in this work, we confirmed and
extended previous data showing the existence of four
main K1 subtypes, as described by Zong et al. (1999) in
their original study. These authors also proposed the
existence of distinct groups within these main subtypes
on the basis of “specific sequences signatures.” We have
confirmed that some of these groups have specific mu-
tations. However, as previously noted on a smaller series
of partial or complete K1 sequences, originating from
both KS tumor and asymptomatic individuals, phyloge-
netic studies did not rigorously support some of these
molecular groups (Cook et al., 1999). Thus A1, A2, and A4
sequences are quite closely related, and only a large
group comprising all of the A1 to A4 strains seems well
supported phylogenetically. Indeed, based on high boot-
strap values and consistent topological associations, by
adding many new viral strains, we were able to better
define several molecular groups within each of the main
subtypes. Thus, for subtype B, with the addition of 14 new
complete K1 sequences to the available six complete
ones, our study clearly identified three main groups (B1,
B2, and B3) within this subtype, in which the B3 was
represented by a new African isolate of our series. Fur-
thermore, for some of these groups, very few complete
K1 sequences were available before our study. For in-
stance, the third group of the A subtype, which corre-
sponds to the A5 group (Zong et al., 1999), now com-
prises 12 complete K1 sequences, 11 of which were
generated in this study. Similarly, the first group of the C
subtype now comprises eight complete K1 sequences, of
which six were obtained in this study. Meng et al. (1999)
also previously described groups within subtype A (sub-
type I in their classification) and subtype C (their subtype
II) by using phylogenetic studies, although performed on
fewer K1 strains. Interestingly, among our 52 new K1
sequences, we described two new divergent strains,
which can be considered as an early/ancient strains of
the C subtype for one and of the whole set of A/C strains
for the second one.
Our study emphasizes that classification of HHV8 in
separate subtypes or groups, at least for some strains,
should be considered as temporary and very probably
will be modified with the ongoing description of new
strains originating from patients of different geographic
areas. Moreover, as previously suggested (Cook et al.,
1999), consensus on the criteria used to define a subtype
and a subgroup is urgently required.
Predominance of two major HHV8 K1 subtypes in
Africa
Based on geographic (or ethnic) restriction of molec-
ular subtypes and on calculations that take into account
the estimation of synonymous substitution rates (Mc-
Geoch et al., 1995), two groups (Cook et al., 1999; Zong etal., 1999) proposed that subtype B is older than subtypes
A and C, which could have diverged more recently. In this
scenario, subtype B, originating from Africa, was consid-
ered the most ancient strain, while subtypes A and C
could correspond to the major European and Northern
American HHV8 genotypes. In our series, the finding that
all the strains of subtype B are present in patients from
Africa or of African ancestry heritage and that C strains
are mainly found in French, mostly HIV-infected patients,
fits well with this scenario. However, the finding that half
of the HHV8 strains from patients of Cameroon and
Central African Republic are of the A5 group also sug-
gests an ancient and African origin for this genotype.
Interestingly, the only other complete K1 A5 strain avail-
able was found in a patient living in Tanzania, East Africa
(Zong et al., 1999). Furthermore, in our series, such A5
genotypes were also found in two Creole patients from
French Guiana, a black population originating mainly
through the slave trade from the west coast of Africa.
It is also worthwhile to note that the 12 partial K1
strains from Zambian children reported by Kasolo et al.
(1998), as well as three other incomplete K1 strains from
Uganda (Ug2, Ug3, and Ug374) (Meng et al., 1999; Cook
et al., 1999), also clustered in the same phylogenetic
clade. Thus, the A5 genotype is widespread throughout
Africa, present in Western, Central, Eastern, and South-
ern countries of this continent, and thus represents, with
subtype B, one of the two most prevalent K1 genotypes in
Africa. Indeed, an overall compilation of the 75 complete
or partial K1 gene sequences originating from African
patients or from African origin (Creoles, recent immi-
grants) revealed that 54.7% (41/75) and 40% (30/75) of
them belonged to the B and A5 groups, respectively,
while the other subtypes or groups represented only
5.3% of the strains (Fig. 2). Furthermore, until now these
two genotypes seem mainly restricted to Africa, even if
two A5 strains were reported in patients from Northern
Italy, which already indicates some geographic dissem-
ination of this genotype (Cook et al., 1999).
Regarding Europe, our data clearly demonstrate that
subtype C is the most prevalent in France, at least in
HIV-infected homosexual males, which represent the
major endemic population for HHV8 in this country (Mar-
celin et al., 1998). The situation in Europe taken as a
whole seems more complex, as previously noted in the
largest study of European strains (42 sequences) (Cook
et al., 1999), with subtypes A and C strains found in quite
different and separated geographic areas such as Ice-
land, Greece, or Italy.
Lack of K1 and K14.1/K15 genotype-disease
associationThe possible link between specific HHV8 genotypes
and peculiar diseases (KS, MCD, PEL), implying that
s
a
st/Cent
Centra
70 LACOSTE ET AL.some genotypes may have different biological proper-
ties, was previously suggested by some authors. Thus,
Luppi et al. (1997) suggested that A subtype strains
FIG. 2. Map of Africa with the geographic distribution of the differ
K1-8/Dem. The dotted line separates HHV8 strains originating from We
HHV8 strains are of the K14.1/K15 P genotype, while those from West/predominate in Italian classic KS, whereas C subtype
strains may be more prevalent in Italian nonmalignant
t
glymphoproliferations. In addition, Boralevi et al. (1998)
uggested that subtype A may be responsible for more
ggressive KS tumors in France. Unfortunately, however,
notypes of ORF K1 of HHV8. “?” corresponds to the divergent strain
ral Africa from those originating from East Africa. In East Africa, all the
l Africa comprise an equivalent number of P and M genotypes.ent gehese data were based on a small fragment of the ORF26
ene, recently shown to be ambiguous for subtyping
a
E
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found similar HHV8 genotypes in Zambian children suf-
fering either from KS or being HIV-positive febrile infants.
Regarding the studies based on K1 variability, a lack of
genotype-disease association was found in recent stud-
ies, at least for the A and C subtypes and the different
forms of KS (Cook et al., 1999; Meng et al., 1999; Zong et
al., 1999). Our work, which added 32 KS samples, includ-
ing all clinico-epidemiologic forms, confirms such an
absence of specific K1 subtype associated with KS. Re-
garding PEL, the available and still-limited data on 18
cases, including our five new cases, revealed either an A
or a C subtype. However, no PEL has yet been reported
in African patients, thus explaining the lack of associa-
tion between B or A5 genotype with PEL. Regarding
MCD, there were only three cases for which a K1 se-
quence was previously reported (two HIV-negative cases
from Italy and one HIV-positive case from Australia)
(Cook et al., 1999; Meng et al., 1999). Our studies, by
adding 12 new MCD cases, originating from North, West,
and Central Africa as well as from Spain, South America,
and France, make it clear that HHV8 strains of the A, B,
and C subtypes can be found in tumoral lesions of MCD
patients, with or without HIV infection.
K14.1/K15 variability
A previous study of the genetic variability at multiple
loci of more than 60 HHV8 isolates identified an ex-
tremely high degree of divergence at the RHS of the
genome that allowed the subdivision of all isolates into
two subtypes, or alleles, called P (for predominant) and
M (for minor) (Poole et al., 1999). For some viral strains,
the sequence divergence at the K15 gene between the P
and M subtypes extended leftward, although attenuated,
up to the K12 gene. Whereas the hypervariability of K1 is
likely to represent a rapid evolution of the modern form of
HHV8, the very low level of nucleotide variation found
within either the P or M allele suggests that the RHS M
form may have originated from an ancient recombination
event with an HHV8-like virus, possibly from another Old
World primate (Poole et al., 1999). It also appeared in this
study that the P and M K15 alleles were only partially
linked to the left-hand side K1 subtype. We confirm in our
study the existence of the P and M K15 subtypes, but
interestingly, we did find a significant linkage with the
LHS K1 subtype. Thus, the great majority of the C and A
K1 subtypes (25 strains, 19 of which are of non-African
origin), with the exception of the A5 clade, were of the P
K15 subtype, whereas the B and A5 K1 subtypes (25
strains all African or from African heritage) contained an
equal proportion of P and M alleles. Thus, in contrast
with the study cited above, in which all the HHV8 strains
from Africa were of the P subtype, we found the presence
of both P and M subtypes only in HHV8 strains of African
p
Korigin (Fig. 2). A possible explanation for this apparent
discrepancy is that all our African samples were from
Central or West Africa (and originated from West Africa in
the case of patients from French Guiana), whereas the
African samples previously studied were mostly from
East Africa (Poole et al., 1999). The finding of an M locus
in a Haitian black patient with KS infected by a B K1
strain (Poole et al., 1999) agrees with this scenario. The
predominance of the P subtype in East African KS pa-
tients may thus be in consequence of a founder effect
that would fit with the pattern of human migrations in
Africa, spreading from West and Central Africa to the
Eastern and Southern parts of this continent (Cavalli
Sforza et al., 1994). Indeed, a similar observation was
made in the case of HTLV-1, where viral strains are more
heterogeneous in West and Central Africa than in more
recently populated South Africa (Mahieux et al., 1997).
Founder effects may also explain the predominance of
the P subtype in our samples from France and that of the
M subtype in a few Chinese KS patients from Taiwan
(Poole et al., 1999). The overall predominance of the P
subtype in regions other than Central/West Africa, should
it be confirmed by further genotyping studies, raises the
possibility of a functional difference between the two
viral genotypes, conferring for instance a higher trans-
missibility to the P subtype.
MATERIALS AND METHODS
Patient samples
Patient samples for this study included fresh frozen
biopsies of AIDS-associated, posttransplant, endemic or
classic (HIV-negative) KS patients, as well as of MCD
patients (either HIV- or non-HIV-associated) and PEL
samples of HIV-infected patients (Fouchard et al., 2000;
Gessain et al., 1996, 1997; Judde et al., 2000). The main
epidemiologic features of the patients as well as the type
of the samples are summarized in Table 1. The fresh
frozen tumor biopsies were minced into small fragments
with a scalpel and were incubated overnight at 65°C in
10 mM Tris–HCl, pH 8, 5 mM EDTA, 50 mM NaCl, 0.5%
SDS, and 200 mg/ml proteinase K. High-molecular-
weight DNA was extracted by a classical phenol, phenol-
chloroform, and chloroform technique and precipitated
by isopropanol.
Polymerase chain reaction
ORF K1 amplification. The 870-bp ORF K1 coding re-
gion from nucleotide positions 105 to 974, as numbered
according to the strain BC1 (Russo et al., 1996), was
mplified directly, using the AmpliTaq Gold (Perkin–
lmer, Branchburg, NJ), from HHV8-positive DNA sam-
les as a 1073-bp PCR product using the following ORF
1-specific oligonucleotide primers (genomic nucleotide
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72 LACOSTE ET AL.positions indicated in parentheses): K1AG75S, 59 (76)
GACCTTGTTGGACATCCCGTACAATC (101) 39 (sense),
K1AG1200AS, 59 (1148) AGGCCATGCTGTAAGTAGCACG-
GTT (1124) 39 (antisense).
ORF K14.1/K15 molecular characterization. Molecular
subtype characterization of the right-hand side (RHS) of
the HHV8 genome was determined as previously de-
scribed (Poole et al., 1999). Two different PCR strategies
were used, a single PCR using a pair of primers unique
to the M subtype of ORF K15 and a triple primer PCR set
of ORF K14.1, covering the divergent junction of the two
subtypes of ORF K15 genes. For all experiments, strin-
gent precautions against PCR contamination were taken.
The amplification mixes were made in a special room
physically separated from the laboratory and at least two
negative control (mix, water, or cellular DNA prepared
from an HHV8-negative sample) were included. After
denaturation at 95°C for 10 min, the reaction mixtures
containing DNA were cycled 35 times at 94°C for 1 min,
55.5°C for 1 min, 72°C for 2 min, and a 10-min extension
at 72°C on the last cycle (Perkin–Elmer GeneAmp PCR
system 9600 thermal cycler). An aliquot of these ampli-
fication products was electrophoresed in a 1% agarose
gel, stained with 0.5 mg/ml ethidium bromide, and visu-
alized under UV transillumination.
Cloning
Amplification products of the predicted size (1073 bp)
were cloned into INVaF9 bacterial cells using the TA
cloning kit from Invitrogen (Carlsbad, CA). White colonies
were picked and grown in LB broth in the presence of
ampicillin at 37°C overnight. Plasmid DNA was prepared
from single isolated colonies, after confirmation of the
presence of the appropriately sized insert by digestion
with EcoRI, using Qiagen plasmids kits and following the
manufacturer’s protocol (Qiagen, Du¨sseldorf, Germany),
and these plasmids were used for sequencing.
Nucleotide sequencing
The inserted fragment was sequenced by Eurogentec
(Seraing, Belgium) using the BigDye Terminator technol-
ogy and following the manufacturer’s protocol (Applied
BioSystems/Perkin–Elmer, Foster City, CA). Briefly, 250
ng of plasmid DNA and 3.2 pmol of primer were mixed in
a 20-ml total volume reaction with 8 ml of the BigDye
premix solution. Twenty-five cycles of sequencing reac-
tion were performed in a thermocycler (model 9700;
Perkin–Elmer Cetus Instruments, Norwalk, CT). The se-
quencing reaction products were purified by isopropanol
precipitation and resuspended in 2 ml of loading buffer
as described by the manufacturer. A 0.5-ml sample was
oaded with an eight-channel Hamilton syringe (Hamil-
on, Reno, NV) on an 5% long Ranger (FMC BioProducts,
ockland, ME) 36-cm-long slab gel, resolved on anBI377 instrument (Applied BioSystems), and analyzed
ith Analysis software version 3.3 (Applied BioSystems).
oth strands were fully sequenced by the primer walking
ethod. Internal primers were designed and synthesized
y Eurogentec. Contig assembly was performed using
he Sequencher package version 3.0 (Gene Codes, Ann
rbor, MI).
hylogenetic analyses
Several steps were carried out to derive phylogenetic
rees from the original set of sequences. The alignment
f multiple sequences was performed by using the
lustal W program. The resulting aligned sequences
ere submitted to different programs of the PHYLIP
ackage (version 3.52c; Joseph Felsenstein, University of
ashington, E-mail: joe@genetics.washington.edu). Two
ethods were used to generate phylogenetic trees, the
aximum parsimony method using the DNAPARS pro-
ram and the neighbor-joining (NJ) NEIGHBOR program
ethod, using the modified NJ approach. The latter
ethod uses the modified Kimura two-parameter dis-
ance, which is a maximum likelihood estimate of Kimura
istance for a fixed value of a/b (transition/transversion
ratio 5 2). The SEQBOOT program was carried out to
enerate 100 to 500 data sets that are randomly resa-
pled versions of the previously aligned sequences to
est the reliability of the final tree topology. A consensus
ree was constructed by using the CONSENSE program
ith the majority rule criterion. The bootstrap values
btained were added to the neighbor-joining distance-
ased tree constructed. Protein sequences were also
nalyzed by a distance method, using the PAM matrix
rom PROTDIST in the PHYLIP package, followed by
onstruction of a neighbor-joining tree. Bootstrap values
100 replica samplings) were derived with the SEQBOOT
rogram and added to the NJ tree. The 52 new entire
RF K1 sequences determined herein were deposited in
he National Center for Biotechnology Information data-
ase. GenBank accession numbers, listed in Table 1, are
F171056 through AF171059, AF178773 through
F178834, AF196316, and AF196317.
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